{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:21:51Z","timestamp":1787908911477,"version":"build-2784847793"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05617-8","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:57:13Z","timestamp":1782374233000},"page":"3635-3652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The factors between BMI and diabetic nephropathy and protective role of the FGF21-SIRT1 axis in diabetic nephropathy"],"prefix":"10.1007","volume":"481","author":[{"given":"Chao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-3528","authenticated-orcid":false,"given":"Qiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"2","key":"5617_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1210\/er.2017-00253","volume":"39","author":"GA Bray","year":"2018","unstructured":"Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M et al (2018) The science of obesity management: an Endocrine Society scientific statement. Endocr Rev 39(2):79\u2013132. https:\/\/doi.org\/10.1210\/er.2017-00253","journal-title":"Endocr Rev"},{"issue":"8","key":"5617_CR2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.jamda.2020.10.035","volume":"22","author":"SW Jung","year":"2021","unstructured":"Jung SW, Cho M, Oh W, Ko GJ, Moon JY, Lee SH et al (2021) Incremental effect of aging on obesity-related incident chronic kidney disease in the Korean general population. J Am Med Dir Assoc 22(8):1751-1756e.e2. https:\/\/doi.org\/10.1016\/j.jamda.2020.10.035","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"5617_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2203517","volume":"55","author":"R Abdul Wahab","year":"2023","unstructured":"Abdul Wahab R, Cohen RV, le Roux CW (2023) Recent advances in the treatment of patients with obesity and chronic kidney disease. Ann Med 55(1):2203517. https:\/\/doi.org\/10.1080\/07853890.2023.2203517","journal-title":"Ann Med"},{"issue":"1","key":"5617_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s10157-018-1606-y","volume":"23","author":"A Kuma","year":"2019","unstructured":"Kuma A, Uchino B, Ochiai Y, Kawashima M, Enta K, Tamura M et al (2019) Relationship between abdominal adiposity and incident chronic kidney disease in young- to middle-aged working men: a retrospective cohort study. Clin Exp Nephrol 23(1):76\u201384. https:\/\/doi.org\/10.1007\/s10157-018-1606-y","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"5617_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","volume":"107","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dominguez M, Golestaneh L (2023) Diabetic kidney disease: an update. Med Clin North Am 107(4):689\u2013705. https:\/\/doi.org\/10.1016\/j.mcna.2023.03.004","journal-title":"Med Clin North Am"},{"issue":"1","key":"5617_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1159\/000534832","volume":"48","author":"F Wen","year":"2023","unstructured":"Wen F, Zhang S, Sun L, Qian M, Xu H (2023) Salvianolic acid B inhibits oxidative stress in glomerular mesangial cells alleviating diabetic nephropathy by regulating SIRT3\/FOXO1 signaling. Kidney Blood Press Res 48(1):738\u2013751. https:\/\/doi.org\/10.1159\/000534832","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"5617_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ymthe.2020.01.014","volume":"28","author":"YC Tsai","year":"2020","unstructured":"Tsai YC, Kuo MC, Hung WW, Wu LY, Wu PH, Chang WA et al (2020) High glucose induces mesangial cell apoptosis through miR-15b-5p and promotes diabetic nephropathy by extracellular vesicle delivery. Mol Ther 28(3):963\u2013974. https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.014","journal-title":"Mol Ther"},{"issue":"6","key":"5617_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2337\/db23-0811","volume":"73","author":"Y Xie","year":"2024","unstructured":"Xie Y, Yuan Q, Tang B et al (2024) CPT1A protects podocytes from lipotoxicity and apoptosis in vitro and alleviates diabetic nephropathy in vivo. Diabetes 73(6):879\u2013895. https:\/\/doi.org\/10.2337\/db23-0811","journal-title":"Diabetes"},{"issue":"7","key":"5617_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072632","volume":"21","author":"L Opazo-R\u00edos","year":"2020","unstructured":"Opazo-R\u00edos L, Mas S, Mar\u00edn-Royo G, Mezzano S, G\u00f3mez-Guerrero C, Moreno JA et al (2020) Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci 21(7):2632. https:\/\/doi.org\/10.3390\/ijms21072632","journal-title":"Int J Mol Sci"},{"key":"5617_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4509403","volume":"2019","author":"D Kim","year":"2019","unstructured":"Kim D, Kim HJ, Cha SH, Jun HS (2019) Protective effects of Broussonetia kazinoki Siebold fruit extract against palmitate-induced lipotoxicity in mesangial cells. Evid Based Complement Alternat Med 2019:4509403. https:\/\/doi.org\/10.1155\/2019\/4509403","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"5617_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/JOE-18-0206","volume":"240","author":"ES Lee","year":"2019","unstructured":"Lee ES, Kwon MH, Kim HM, Kim N, Kim YM, Kim HS et al (2019) Dibenzoylmethane ameliorates lipid-induced inflammation and oxidative injury in diabetic nephropathy. J Endocrinol 240(2):169\u2013179. https:\/\/doi.org\/10.1530\/JOE-18-0206","journal-title":"J Endocrinol"},{"issue":"8","key":"5617_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087556","volume":"24","author":"RS Goutam","year":"2023","unstructured":"Goutam RS, Kumar V, Lee U, Kim J (2023) Exploring the structural and functional diversity among FGF signals: a comparative study of human, mouse, and xenopus FGF ligands in embryonic development and cancer pathogenesis. Int J Mol Sci 24(8):7556. https:\/\/doi.org\/10.3390\/ijms24087556","journal-title":"Int J Mol Sci"},{"key":"5617_CR13","doi-asserted-by":"publisher","first-page":"154738","DOI":"10.1016\/j.metabol.2021.154738","volume":"118","author":"JV Salgado","year":"2021","unstructured":"Salgado JV, Goes MA, Salgado Filho N (2021) FGF21 and chronic kidney disease. Metabolism 118:154738. https:\/\/doi.org\/10.1016\/j.metabol.2021.154738","journal-title":"Metabolism"},{"issue":"4","key":"5617_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.2010010098","volume":"22","author":"I Loeffler","year":"2011","unstructured":"Loeffler I, Hopfer U, Koczan D, Wolf G (2011) Type VIII collagen modulates TGF-\u03b21-induced proliferation of mesangial cells. J Am Soc Nephrol 22(4):649\u2013663. https:\/\/doi.org\/10.1681\/ASN.2010010098","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5617_CR15","doi-asserted-by":"publisher","first-page":"2179336","DOI":"10.1080\/0886022X.2023.2179336","volume":"45","author":"G Yong","year":"2023","unstructured":"Yong G, Li L, Hu S (2023) Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis. Ren Fail 45(1):2179336. https:\/\/doi.org\/10.1080\/0886022X.2023.2179336","journal-title":"Ren Fail"},{"key":"5617_CR16","doi-asserted-by":"publisher","first-page":"846018","DOI":"10.3389\/fendo.2022.846018","volume":"13","author":"LH Chang","year":"2022","unstructured":"Chang LH, Chu CH, Huang CC, Lin LY (2022) Fibroblast growth factor 21 levels exhibit the association with renal outcomes in subjects with type 2 diabetes mellitus. Front Endocrinol (Lausanne) 13:846018. https:\/\/doi.org\/10.3389\/fendo.2022.846018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5617_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-022-01232-3","volume":"8","author":"H Liu","year":"2023","unstructured":"Liu H, Duan C, Yang X, Liu J, Deng Y, Tiselius HG et al (2023) Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation. Signal Transduct Target Ther 8(1):38. https:\/\/doi.org\/10.1038\/s41392-022-01232-3","journal-title":"Signal Transduct Target Ther"},{"key":"5617_CR18","doi-asserted-by":"publisher","first-page":"109605","DOI":"10.1016\/j.cbi.2021.109605","volume":"347","author":"QL Ye","year":"2021","unstructured":"Ye QL, Wang DM, Wang X, Zhang ZQ, Tian QX, Feng SY et al (2021) Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury. Chem Biol Interact 347:109605. https:\/\/doi.org\/10.1016\/j.cbi.2021.109605","journal-title":"Chem Biol Interact"},{"key":"5617_CR19","doi-asserted-by":"publisher","first-page":"155378","DOI":"10.1016\/j.metabol.2022.155378","volume":"139","author":"S Li","year":"2023","unstructured":"Li S, Lin Z, Xiao H, Xu Z, Li C, Zeng J et al (2023) Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis. Metabolism 139:155378. https:\/\/doi.org\/10.1016\/j.metabol.2022.155378","journal-title":"Metabolism"},{"issue":"5","key":"5617_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13812","volume":"22","author":"Y Yu","year":"2023","unstructured":"Yu Y, Song X, Wang X, Zheng L, Ma G, Liu W et al (2023) Oxidative stress impairs the Nur77-Sirt1 axis resulting in a decline in organism homeostasis during aging. Aging Cell 22(5):e13812. https:\/\/doi.org\/10.1111\/acel.13812","journal-title":"Aging Cell"},{"key":"5617_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.925738","volume":"13","author":"Y Fu","year":"2022","unstructured":"Fu Y, Wang Y, Liu Y, Tang C, Cai J, Chen G et al (2022) p53\/sirtuin 1\/NF-\u03baB signaling axis in chronic inflammation and maladaptive kidney repair after cisplatin nephrotoxicity. Front Immunol 13:925738. https:\/\/doi.org\/10.3389\/fimmu.2022.925738","journal-title":"Front Immunol"},{"issue":"7\u20138","key":"5617_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10495-023-01858-w","volume":"28","author":"R Zhang","year":"2023","unstructured":"Zhang R, Bian C, Gao J, Ren H (2023) Endoplasmic reticulum stress in diabetic kidney disease: adaptation and apoptosis after three UPR pathways. Apoptosis 28(7\u20138):977\u2013996. https:\/\/doi.org\/10.1007\/s10495-023-01858-w","journal-title":"Apoptosis"},{"issue":"7","key":"5617_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41401-021-00805-2","volume":"43","author":"FF Ren","year":"2022","unstructured":"Ren FF, Xie ZY, Jiang YN, Guan X, Chen QY, Lai TF et al (2022) Dapagliflozin attenuates pressure overload-induced myocardial remodeling in mice via activating SIRT1 and inhibiting endoplasmic reticulum stress. Acta Pharmacol Sin 43(7):1721\u20131732. https:\/\/doi.org\/10.1038\/s41401-021-00805-2","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"5617_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073185","volume":"28","author":"N Lei","year":"2023","unstructured":"Lei N, Song H, Zeng L, Ji S, Meng X, Zhu X et al (2023) Persistent lipid accumulation leads to persistent exacerbation of endoplasmic reticulum stress and inflammation in progressive NASH via the IRE1\u03b1\/TRAF2 complex. Molecules 28(7):3185. https:\/\/doi.org\/10.3390\/molecules28073185","journal-title":"Molecules"},{"issue":"1","key":"5617_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010073","volume":"11","author":"E Figueroa-Ju\u00e1rez","year":"2021","unstructured":"Figueroa-Ju\u00e1rez E, Noriega LG, P\u00e9rez-Monter C, Alem\u00e1n G, Hern\u00e1ndez-Pando R, Correa-Rotter R et al (2021) The role of the unfolded protein response on renal lipogenesis in C57BL\/6 mice. Biomolecules 11(1):73. https:\/\/doi.org\/10.3390\/biom11010073","journal-title":"Biomolecules"},{"issue":"5","key":"5617_CR26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.kint.2022.11.024","volume":"103","author":"V Krausel","year":"2023","unstructured":"Krausel V, Pund L, N\u00fcsse H, Bachir H, Ricker A, Klingauf J et al (2023) The transcription factor ATF4 mediates endoplasmic reticulum stress-related podocyte injury and slit diaphragm defects. Kidney Int 103(5):872\u2013885. https:\/\/doi.org\/10.1016\/j.kint.2022.11.024","journal-title":"Kidney Int"},{"issue":"2","key":"5617_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.kint.2022.09.024","volume":"103","author":"S Krishnan","year":"2023","unstructured":"Krishnan S, Manoharan J, Wang H, Gupta D, Fatima S, Yu Y et al (2023) CD248 induces a maladaptive unfolded protein response in diabetic kidney disease. Kidney Int 103(2):304\u2013319. https:\/\/doi.org\/10.1016\/j.kint.2022.09.024","journal-title":"Kidney Int"},{"issue":"1","key":"5617_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.7150\/ijbs.28873","volume":"15","author":"Y Shi","year":"2019","unstructured":"Shi Y, Wang S, Peng H, Lv Y, Li W, Cheng S et al (2019) Fibroblast growth factor 21 attenuates vascular calcification by alleviating endoplasmic reticulum stress mediated apoptosis in rats. Int J Biol Sci 15(1):138\u2013147. https:\/\/doi.org\/10.7150\/ijbs.28873","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5617_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03056-x","volume":"24","author":"JD Kampmann","year":"2023","unstructured":"Kampmann JD, Heaf JG, Mogensen CB, Mickley H, Wolff DL, Brandt F (2023) Prevalence and incidence of chronic kidney disease stage 3\u20135 - results from KidDiCo. BMC Nephrol 24(1):17. https:\/\/doi.org\/10.1186\/s12882-023-03056-x","journal-title":"BMC Nephrol"},{"key":"5617_CR30","first-page":"151","volume":"17","author":"J Chalmers","year":"1999","unstructured":"Chalmers J (1999) World Health Organization-International society of hypertension guidelines for the management of hypertension. Guidelines Subcommittee. Journal of Hypertension 17:151\u2013183","journal-title":"Journal of Hypertension"},{"issue":"1","key":"5617_CR31","first-page":"83","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2013study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15(1):83\u201396","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"5617_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5935\/0101-2800.20160065","volume":"38","author":"M Fouad","year":"2016","unstructured":"Fouad M, Fathy H, Zidan A (2016) Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients. J Bras Nefrol 38(4):403\u2013410","journal-title":"J Bras Nefrol"},{"issue":"1","key":"5617_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2337\/dc11-1346","volume":"35","author":"G Zoppini","year":"2012","unstructured":"Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E (2012) Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 35(1):99\u2013104","journal-title":"Diabetes Care"},{"key":"5617_CR34","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2017.0065","author":"KS Kim","year":"2018","unstructured":"Kim KS, Park SW, Cho YW, Kim SK (2018) Higher prevalence and progression rate of chronic kidney disease in elderly patients with type 2 diabetes mellitus. Diabetes Metab J. https:\/\/doi.org\/10.4093\/dmj.2017.0065","journal-title":"Diabetes Metab J"},{"issue":"2","key":"5617_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrneph.2015.173","volume":"12","author":"MC Thomas","year":"2016","unstructured":"Thomas MC, Cooper ME, Zimmet P (2016) Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol 12(2):73\u201381. https:\/\/doi.org\/10.1038\/nrneph.2015.173","journal-title":"Nat Rev Nephrol"},{"key":"5617_CR36","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.2147\/DMSO.S469692","volume":"17","author":"Y Miao","year":"2024","unstructured":"Miao Y, Wang Y, Wang Y, Yan P, Chen Z, Wan Q (2024) The association between triglyceride-glucose index and its combination with obesity indicators and lower extremity peripheral artery disease in patients with type 2 diabetes mellitus: a cross-sectional study. Diabetes Metab Syndr Obes 17:2607\u20132617. https:\/\/doi.org\/10.2147\/DMSO.S469692","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5617_CR37","doi-asserted-by":"publisher","first-page":"110602","DOI":"10.1016\/j.diabres.2023.110602","volume":"198","author":"C Li","year":"2023","unstructured":"Li C, Wang W, Ji Q et al (2023) Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China. Diabetes Res Clin Pract 198:110602. https:\/\/doi.org\/10.1016\/j.diabres.2023.110602","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"5617_CR38","doi-asserted-by":"publisher","first-page":"e70087","DOI":"10.1002\/edm2.70087","volume":"8","author":"W Zhang","year":"2025","unstructured":"Zhang W, Liu Y (2025) The obesity-related indices are useful for predicting diabetic nephropathy in patients with type II diabetes mellitus: a retrospective cohort study of NHANES. Endocrinol Diabetes Metab 8(5):e70087. https:\/\/doi.org\/10.1002\/edm2.70087","journal-title":"Endocrinol Diabetes Metab"},{"issue":"6","key":"5617_CR39","doi-asserted-by":"publisher","first-page":"F1720","DOI":"10.1152\/ajprenal.00536.2017","volume":"315","author":"LC Li","year":"2018","unstructured":"Li LC, Yang JL, Lee WC, Chen JB, Lee CT, Wang PW et al (2018) Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice. Am J Physiol Ren Physiol 315(6):F1720\u2013F1731. https:\/\/doi.org\/10.1152\/ajprenal.00536.2017","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"5617_CR40","doi-asserted-by":"publisher","first-page":"e14045","DOI":"10.1111\/apha.14045","volume":"239","author":"R Boi","year":"2023","unstructured":"Boi R, Ebefors K, Nystr\u00f6m J (2023) The role of the mesangium in glomerular function. Acta Physiol (Oxf) 239(2):e14045. https:\/\/doi.org\/10.1111\/apha.14045","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"5617_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1681\/ASN.2008050549","volume":"20","author":"D Schl\u00f6ndorff","year":"2009","unstructured":"Schl\u00f6ndorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20(6):1179\u20131187. https:\/\/doi.org\/10.1681\/ASN.2008050549","journal-title":"J Am Soc Nephrol"},{"key":"5617_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03083","volume":"9","author":"H Hu","year":"2019","unstructured":"Hu H, Tian M, Ding C, Yu S (2019) The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol 9:3083. https:\/\/doi.org\/10.3389\/fimmu.2018.03083","journal-title":"Front Immunol"},{"key":"5617_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR (2015) The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol 10:173\u2013194. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104649","journal-title":"Annu Rev Pathol"},{"key":"5617_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.arr.2017.05.004","volume":"37","author":"A Salminen","year":"2017","unstructured":"Salminen A, Kaarniranta K, Kauppinen A (2017) Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses. Ageing Res Rev 37:79\u201393. https:\/\/doi.org\/10.1016\/j.arr.2017.05.004","journal-title":"Ageing Res Rev"},{"key":"5617_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","volume":"38","author":"LD BonDurant","year":"2018","unstructured":"BonDurant LD, Potthoff MJ (2018) Fibroblast growth factor 21: a versatile regulator of metabolic homeostasis. Annu Rev Nutr 38:173\u2013196. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064800","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"5617_CR46","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.mayocp.2024.10.026","volume":"100","author":"HB Koh","year":"2025","unstructured":"Koh HB, Kim HJ, Kim HW et al (2025) Plasma levels of fibroblast growth factor 21 and adverse kidney outcomes. Mayo Clin Proc 100(8):1345\u20131359. https:\/\/doi.org\/10.1016\/j.mayocp.2024.10.026","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"5617_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00125-021-05613-1","volume":"65","author":"F Cheng","year":"2022","unstructured":"Cheng F, Luk AO, Wu H et al (2022) Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register. Diabetologia 65(2):375\u2013386. https:\/\/doi.org\/10.1007\/s00125-021-05613-1","journal-title":"Diabetologia"},{"key":"5617_CR48","doi-asserted-by":"publisher","first-page":"1053997","DOI":"10.3389\/fcvm.2022.1053997","volume":"9","author":"F Yan","year":"2022","unstructured":"Yan F, Yuan L, Yang F, Wu G, Jiang X (2022) Emerging roles of fibroblast growth factor 21 in critical disease. Front Cardiovasc Med 9:1053997. https:\/\/doi.org\/10.3389\/fcvm.2022.1053997","journal-title":"Front Cardiovasc Med"},{"key":"5617_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00241","volume":"11","author":"Q Chen","year":"2020","unstructured":"Chen Q, Ma J, Yang X, Li Q, Lin Z, Gong F (2020) SIRT1 mediates effects of FGF21 to ameliorate cisplatin-induced acute kidney injury. Front Pharmacol 11:241. https:\/\/doi.org\/10.3389\/fphar.2020.00241","journal-title":"Front Pharmacol"},{"issue":"20","key":"5617_CR50","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","volume":"146","author":"L Jin","year":"2022","unstructured":"Jin L, Geng L, Ying L, Shu L, Ye K, Yang R et al (2022) FGF21-Sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity. Circulation 146(20):1537\u20131557. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059631","journal-title":"Circulation"},{"issue":"2","key":"5617_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0307-5","volume":"9","author":"H Yang","year":"2018","unstructured":"Yang H, Feng A, Lin S, Yu L, Lin X, Yan X et al (2018) Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Cell Death Dis 9(2):227. https:\/\/doi.org\/10.1038\/s41419-018-0307-5","journal-title":"Cell Death Dis"},{"issue":"35","key":"5617_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz9890","volume":"6","author":"CA Gilroy","year":"2020","unstructured":"Gilroy CA, Capozzi ME, Varanko AK, Tong J, D\u2019Alessio DA, Campbell JE et al (2020) Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia. Science Advances 6(35):eaaz9890. https:\/\/doi.org\/10.1126\/sciadv.aaz9890","journal-title":"Science Advances"},{"key":"5617_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103202","volume":"63","author":"Q Pan","year":"2021","unstructured":"Pan Q, Lin S, Li Y, Liu L, Li X, Gao X et al (2021) A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. EBioMedicine 63:103202. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103202","journal-title":"EBioMedicine"},{"issue":"4","key":"5617_CR54","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4093\/dmj.2019.0089","volume":"44","author":"W Weng","year":"2020","unstructured":"Weng W, Ge T, Wang Y et al (2020) Therapeutic effects of fibroblast growth factor-21 on diabetic nephropathy and the possible mechanism in type 1 diabetes mellitus mice. Diabetes Metab J 44(4):566\u2013580. https:\/\/doi.org\/10.4093\/dmj.2019.0089","journal-title":"Diabetes Metab J"},{"issue":"2","key":"5617_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263774","volume":"17","author":"H Taniguchi","year":"2022","unstructured":"Taniguchi H, Nirengi S, Ishihara K, Sakane N (2022) Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus. PLoS One 17(2):e0263774. https:\/\/doi.org\/10.1371\/journal.pone.0263774","journal-title":"PLoS One"},{"issue":"6","key":"5617_CR56","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.kint.2017.12.008","volume":"93","author":"Q Hong","year":"2018","unstructured":"Hong Q, Zhang L, Das B, Li Z, Liu B, Cai G et al (2018) Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. Kidney Int 93(6):1330\u20131343. https:\/\/doi.org\/10.1016\/j.kint.2017.12.008","journal-title":"Kidney Int"},{"issue":"11","key":"5617_CR57","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/nm.3363","volume":"19","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa K, Wakino S, Simic P, Sakamaki Y, Minakuchi H, Fujimura K et al (2013) Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 19(11):1496\u20131504. https:\/\/doi.org\/10.1038\/nm.3363","journal-title":"Nat Med"},{"issue":"8","key":"5617_CR58","doi-asserted-by":"publisher","first-page":"119265","DOI":"10.1016\/j.bbamcr.2022.119265","volume":"1869","author":"X Yu","year":"2022","unstructured":"Yu X, Xu X, Dong W, Yang C, Luo Y, He Y (2022) DDIT3\/CHOP mediates the inhibitory effect of ER stress on chondrocyte differentiation by AMPK\u03b1-SIRT1 pathway. Biochim Biophys Acta Mol Cell Res 1869(8):119265. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119265","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"5617_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.598230","volume":"15","author":"F Li","year":"2021","unstructured":"Li F, Geng X, Lee H, Wills M, Ding Y (2021) Neuroprotective effects of exercise postconditioning after stroke via SIRT1-mediated suppression of endoplasmic reticulum (ER) stress. Front Cell Neurosci 15:598230. https:\/\/doi.org\/10.3389\/fncel.2021.598230","journal-title":"Front Cell Neurosci"},{"key":"5617_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110601","volume":"130","author":"F Wang","year":"2020","unstructured":"Wang F, Yao S, Xia H (2020) SIRT1 is a key regulatory target for the treatment of the endoplasmic reticulum stress-related organ damage. Biomed Pharmacother 130:110601. https:\/\/doi.org\/10.1016\/j.biopha.2020.110601","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"5617_CR61","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3892\/ijmm.2020.4647","volume":"46","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhang L, Zha D, Wu X (2020) Inhibition of miRNA-135a-5p ameliorates TGF-\u03b21-induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy. Int J Mol Med 46(3):1063\u20131073. https:\/\/doi.org\/10.3892\/ijmm.2020.4647","journal-title":"Int J Mol Med"},{"key":"5617_CR62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.mce.2014.08.014","volume":"399","author":"K Huang","year":"2015","unstructured":"Huang K, Chen C, Hao J, Huang J, Wang S, Liu P et al (2015) Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-\u03b21 in rat glomerular messangial cells. Mol Cell Endocrinol 399:178\u2013189. https:\/\/doi.org\/10.1016\/j.mce.2014.08.014","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"5617_CR63","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/bph.15701","volume":"179","author":"X Chen","year":"2022","unstructured":"Chen X, Tong G, Fan J, Shen Y, Wang N, Gong W et al (2022) FGF21 promotes migration and differentiation of epidermal cells during wound healing via SIRT1-dependent autophagy. Br J Pharmacol 179(5):1102\u20131121. https:\/\/doi.org\/10.1111\/bph.15701","journal-title":"Br J Pharmacol"},{"issue":"10","key":"5617_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04157-x","volume":"12","author":"H Lu","year":"2021","unstructured":"Lu H, Jia C, Wu D, Jin H, Lin Z, Pan J et al (2021) Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway. Cell Death Dis 12(10):865. https:\/\/doi.org\/10.1038\/s41419-021-04157-x","journal-title":"Cell Death Dis"},{"issue":"6","key":"5617_CR65","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1096\/fj.201701316R","volume":"32","author":"F Li","year":"2018","unstructured":"Li F, Liu Z, Tang C, Cai J, Dong Z (2018) FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury. FASEB J 32(6):3423\u20133433. https:\/\/doi.org\/10.1096\/fj.201701316R","journal-title":"FASEB J"},{"issue":"5","key":"5617_CR66","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.molcel.2019.03.031","volume":"74","author":"E Balsa","year":"2019","unstructured":"Balsa E, Soustek MS, Thomas A et al (2019) ER and nutrient stress promote assembly of respiratory chain supercomplexes through the PERK-eIF2\u03b1 axis. Mol Cell 74(5):877-890.e6. https:\/\/doi.org\/10.1016\/j.molcel.2019.03.031","journal-title":"Mol Cell"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05617-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05617-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:55Z","timestamp":1787908495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05617-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":66,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5617"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05617-8","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Anhui Medical University. All focus group participants provided signed informed consent prior to the start of the focus groups. Our study also are compliance with the Helsinki Declaration.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}